High-throughput screening and small animal models, where are we?

Jean Giacomotto1, Laurent Ségalat

  • 1Université Claude Bernard Lyon, Villeurbanne, France. giacomottojean@gmail.com <giacomottojean@gmail.com>

Summary

Screening drug candidates in whole organisms like C. elegans, Drosophila, and zebrafish offers advantages over traditional methods. These cost-effective animal models enable high-throughput screening for improved drug discovery and safety profiling.